Home Drug Codes J Codes J9360 · VINBLASTINE SULFATE
Updated July 1st, 2026

VINBLASTINE SULFATE J Code: J9360

Injection, vinblastine sulfate, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9360, effective October 1, 2026: $5.754 per HCPCS billing unit, up 2.6% from $5.608. From CMS's final file.

?
Medicare Payment Limit ?
$5.608
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, vinblastine sulfate, 1 mg
HCPCS Added Date January 1, 1986
Manufacturer Fresenius Kabi
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Multi-Dose
Dosage Form Injection

About VINBLASTINE SULFATE

Vinblastine Sulfate is a medication aligned to the HCPCS J Code: J9360 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Fresenius Kabi.

According to CMS Drug Use Information: Vinblastine is used to treat cancer. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
63323-0278-10 Vinblastine Sulfate Fresenius Kabi USA, LLC 10 10 MG / 10 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

VINBLASTINE SULFATE Pricing & Reimbursement

J9360 Private Payer Reimbursement
$5.36 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

VINBLASTINE SULFATE Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 10.52%
Avg. Days to File 10.7days
Avg. Days to Pay 25.8days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9360 claims analytics on FocalPoint →
OnPoint Oncology

VINBLASTINE SULFATE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96409 Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Login for More Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More
Not on the CMS JW / JZ list

CMS does not include Vinblastine Sulfate (J9360) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9360. Wastage billing guide →

VINBLASTINE SULFATE Medically Unlikely Edits (MUE)

The most billing units of J9360 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
40 units / day
= 40 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

VINBLASTINE SULFATE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Advanced carcinoma of the testis Carcinoma of the breast Choriocarcinoma Generalized Hodgkin's disease Histiocytic lymphoma Kaposi's sarcoma Letterer-Siwe disease (histiocytosis X) Lymphocytic lymphoma Mycosis fungoides
Drug Class
Vinca Alkaloid [EPC]Vinca Alkaloids [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Vinblastine Sulfate billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for VINBLASTINE SULFATE.
Are there any available Vinblastine Sulfate patient assistance programs?
VINBLASTINE SULFATE patient assistance information can be found through Fresenius Kabi. Visit Here →
Where can I find Vinblastine Sulfate prescribing information?
VINBLASTINE SULFATE prescribing information can be found at the link below: Visit Here →
Where can I find Vinblastine Sulfate side effect information?
Information regarding VINBLASTINE SULFATE's side effects can be found at MedlinePlus Visit Here →
Does billing VINBLASTINE SULFATE require JZ/JW wastage modifiers?
CMS does not include VINBLASTINE SULFATE (J9360) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9360. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.